Countdown to 2005 Georgia Life Sciences Summit; Keynote Speakers Include World-Renowned Scientists Drs. George Poste and Thomas Caskey; BIO President James Greenwood.ATLANTA -- The Georgia Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Partnership's (GBP GBP In currencies, this is the abbreviation for the British Pound. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. ) 5th Annual Georgia Life Sciences Summit on October 27 is expected to draw a record crowd to explore this year's topic, the Future of Biomedicine biomedicine /bio·med·i·cine/ (bi?o-med´i-sin) clinical medicine based on the principles of the natural sciences (biology, biochemistry, etc.).biomed´ical bi·o·med·i·cine n. 1. . More than 700 bioscience industry professionals from throughout the Southeast will convene at the Georgia World Congress Center The Georgia World Congress Center or GWCC is the major convention center in Atlanta. It is the fourth-largest convention center in the United States at 1.4 million ft2 (130,000 m2) and hosts more than a million visitors each year. for an exciting scientific and business exposition, featuring more than 40 speakers and 70 exhibitors revealing their most advanced research and product developments. "Each year the Georgia Life Sciences Summit sets a new attendance record," said Charles Craig, president of the Georgia Biomedical Partnership. "Escalating enthusiasm for the Summit reflects the dramatic growth of the state's bioscience industry and its impact far beyond Georgia. The 2005 Summit will be the best ever, showcasing advanced science and R&D at Georgia's publicly traded and privately held companies and the state's world-class universities." Keynote speakers include Drs. George Poste and Thomas Caskey, who are at the forefront of the genomics revolution; James Greenwood, president of Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
Dr. Poste, as R&D chief of SmithKline & French Laboratories in the early 1980s, was among the first in the pharmaceutical industry to embrace the new biotechnology. In the early 1990s, he orchestrated SmithKline Beecham's entry into genomics ahead of his competitors. As director of Arizona State University's Biodesign Institute, he is pioneering a new phase of scientific innovation - the convergence of biology, computing and nanotechnology. Dr. Poste also serves as chair of the U.S. Defense Department's Bioterrorism Task Force. Dr. Caskey, managing director of Cogene Biotech Ventures, served as senior vice president of research for Merck Research Laboratories from 1995 to 2000 and was president of the Merck Genome Research Institute from 1996 to 2000. Previously, as chairman of the Baylor College of Medicine's Department of Human and Molecular Genetics molecular genetics n. The branch of genetics that deals with hereditary transmission and variation on the molecular level. and director of the school's Human Genome Center, he was one of the international leaders in sequencing the human genome. Dr. Caskey is a past president of the International Human Genome Organization. Mr. Greenwood was a U.S. Congressman from Pennsylvania for 12 years before taking over BIO in January 2005. As a leader on health care issues, he authored numerous bills signed into law including legislation to promote pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children. pe·di·at·ric adj. Of or relating to pediatrics. labeling for pharmaceuticals, reform medical device review and approval, and expand research and establish innovative programs to address traumatic brain injury Traumatic brain injury (TBI), traumatic injuries to the brain, also called intracranial injury, or simply head injury, occurs when a sudden trauma causes brain damage. TBI can result from a closed head injury or a penetrating head injury and is one of two subsets of acquired brain . In addition, as chairman of the Energy and Commerce Subcommittee on Oversight and Investigation, Mr. Greenwood led investigations into corporate governance Corporate Governance The relationship between all the stakeholders in a company. This includes the shareholders, directors, and management of a company, as defined by the corporate charter, bylaws, formal policy, and rule of law. at Enron, Global Crossing and WorldCom; terrorist threats to nuclear power plants, ports and infrastructure; and waste and fraud in federal government agencies. In addition to the keynoters, discussion panels will feature speakers from local and regional companies and universities, along with nationally and internationally recognized leaders in science, business, finance, public policy and government. Topics will include advances in personalized medicine, challenges in regulation and reimbursement of modern medicines, changes in investment trends, strategies for biodefense, and efforts to commercialize university research discoveries. An expanded science program will feature presentations by six distinguished scientists on their most advanced research: Dr. Steven Stice, University of Georgia Organization The President of the University of Georgia (as of 2007, Michael F. Adams) is the head administrator and is appointed and overseen by the Georgia Board of Regents. ; Dr. Shuming Nie, Emory University and Georgia Institute of Technology Georgia Institute of Technology, in Atlanta, Ga.; coeducational; state supported; chartered 1885, opened 1888. It is a member school in the university system of Georgia. Significant among its facilities and programs are the Frank H. ; Dr. Jin-Xiong She, Medical College of Georgia In 1828, it was chartered by the state of Georgia as the Medical Academy of Georgia, with plans to offer a single course of lectures leading to a bachelor's degree. It opened the following year on October 1st at the Augusta hospital. ; Dr. Albert Heacox, CryoLife, Inc.; and Dr. Keith Robinson, American Cardiovascular Research Institute. In addition to these presentations, more than 80 scientists from Georgia universities and companies have submitted entries to the poster competition and the winners will be announced at the conclusion of the science program. The full 2005 Georgia Life Sciences Summit program is available at www.gabio.org. Registration for the news media is complimentary. Reporters can register on-site with photo identification from their news organizations. To register in advance, contact Charles Craig at charles.craig@gabio.org or 404-245-0591; or Cindy Carlton, at cindy.carlton@gabio.org or 678-714-3315. The Georgia Biomedical Partnership (GBP), founded in 1989, represents the life sciences industry in Georgia. GBP members include companies, research institutions and universities, government groups and corporate service providers involved in biotechnology, pharmaceuticals, medical devices and diagnostics, medical informatics and related businesses. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion